封面
市场调查报告书
商品编码
1386586

基于 NGS 的 RNA 定序市场报告:2030 年趋势、预测与竞争分析

NGS-Based RNA-Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

基于 NGS 的 RNA 定序趋势和预测

到 2030 年,全球基于 NGS 的 RNA 定序市场预计将达到 84 亿美元,2024 年至 2030 年的年复合成长率为 17.6%。这个市场的主要驱动因素是对个人化医疗的需求不断增长以及人们对 NGS-RNA 定序优势的认识不断提高。全球基于NGS的RNA定序市场前景广阔,在研究/学术、医院/诊所和製药/生技市场中蕴藏着商机。

基于NGS的RNA定序市场洞察

Lucintel 预测,由于基因发现、差异基因表现分析和转录组分析的需求不断增加,表达分析仍将是最大的领域。

由于对个人化医疗的高需求、强大的医疗基础设施以及该地区主要参与者的存在,北美仍将是最大的地区。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球基于NGS的RNA定序市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球基于NGS的RNA定序市场趋势(2018-2023)与预测(2024-2030)
  • 按产品类型分類的全球基于 NGS 的 RNA 定序市场
    • 样品製备产品
    • RNA定序平台与消耗品
    • RNA定序服务
    • 资料分析、储存和管理
  • 按技术分類的全球基于 NGS 的 RNA 定序市场
    • 合成定序
    • 离子半导体序列
    • 单分子即时定序
    • 奈米孔定序
  • 全球基于NGS的RNA定序市场(按应用)
    • 表达谱分析
    • 小RNA定序
    • 从头转录组组装
    • 变异调用和转录组表观磊晶
    • 其他的
  • 全球基于 NGS 的 RNA 定序市场(按最终用途)
    • 研究和学术
    • 医院和诊所
    • 製药和生物技术
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球基于NGS的RNA定序市场(按地区)
  • 北美基于NGS的RNA定序市场
  • 欧洲基于NGS的RNA定序市场
  • 亚太地区基于NGS的RNA定序市场
  • 其他地区则基于NGS的RNA定序市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球基于 NGS 的 RNA 定序市场成长机会
    • 全球基于 NGS 的 RNA 定序市场成长机会(按技术)
    • 全球基于 NGS 的 RNA 定序市场成长机会(按应用)
    • 全球基于 NGS 的 RNA 定序市场成长机会(按最终用途)
    • 全球基于NGS的RNA定序市场成长机会(按地区)
  • 全球基于NGS的RNA定序市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球 NGS RNA 定序市场的产能
    • 全球基于NGS的RNA测序市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Illumina
  • Thermo Fischer Scientific
  • Oxford Nanopore Technologies
  • Agilent Technologies
  • BGI
简介目录

NGS-Based RNA-Sequencing Trends and Forecast

The future of the global NGS-based RNA-sequencing market looks promising with opportunities in the research and academia, hospital and clinic, and pharmaceutical & biotechnology markets. The global NGS-based RNA-sequencing market is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 17.6% from 2024 to 2030. The major drivers for this market are escalating demand for personalized medicine and rising awareness of the benefits of NGS-RNA-sequencing.

A more than 150-page report is developed to help in your business decisions.

NGS-Based RNA-Sequencing by Segment

The study includes a forecast for the global NGS-based RNA-sequencing by product type, technology, application, end use, and region.

NGS-Based RNA-Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sample Preparation Products
  • RNA-sequencing Platforms and Consumables
  • RNA-sequencing Services
  • Data Analysis, Storage & Management

NGS-Based RNA-Sequencing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing

NGS-Based RNA-Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Expression Profiling Analysis
  • Small RNA-Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling & Transcriptome Epigenetics
  • Others

NGS-Based RNA-Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research and Academia
  • Hospitals and Clinics
  • Pharmaceutical & Biotechnology
  • Others

NGS-Based RNA-Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of NGS-Based RNA-Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies NGS-based RNA-sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the NGS-based RNA-sequencing companies profiled in this report include-

  • Illumina
  • Thermo Fischer Scientific
  • Oxford Nanopore Technologies
  • Agilent Technologies
  • BGI

NGS-Based RNA-Sequencing Market Insights

Lucintel forecasts that expression profiling analysis will remain the largest region due to its increasing demand in gene discovery, differential gene expression analysis, and transcriptome profiling.

North America will remain the largest region due to high demand for personalized medicine, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global NGS-Based RNA-Sequencing Market

Market Size Estimates: Ngs-based RNA-sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ngs-based RNA-sequencing market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Ngs-based RNA-sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the NGS-based RNA-sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the NGS-based RNA-sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the NGS-based RNA-sequencing market size?

Answer: The global NGS-based RNA-sequencing market is expected to reach an estimated $8.4 billion by 2030.

Q.2 What is the growth forecast for NGS-based RNA-sequencing market?

Answer: The global NGS-based RNA-sequencing market is expected to grow with a CAGR of 17.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the NGS-based RNA-sequencing market?

Answer: The major drivers for this market are escalating demand for personalized medicine and rising awareness of the benefits of NGS-RNA-sequencing.

Q4. What are the major segments for NGS-based RNA-sequencing market?

Answer: The future of the NGS-based RNA-sequencing market looks promising with opportunities in the research and academia, hospitals and clinics, and pharmaceutical & biotechnology markets.

Q5. Who are the key NGS-based RNA-sequencing market companies?

Answer: Some of the key NGS-based RNA-sequencing companies are as follows:

  • Illumina
  • Thermo Fischer Scientific
  • Oxford Nanopore Technologies
  • Agilent Technologies
  • BGI

Q6. Which NGS-based RNA-sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that expression profiling analysis will remain the largest region due to its increasing demand in gene discovery, differential gene expression analysis, and transcriptome profiling.

Q7. In NGS-based RNA-sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high demand for personalized medicine, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the NGS-based RNA-sequencing market by product type (sample preparation products, RNA-sequencing platforms and consumables, RNA-sequencing services, and data analysis, storage & management), technology (sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing), application (expression profiling analysis, small RNA-sequencing, de novo transcriptome assembly, variant calling & transcriptome epigenetics, and others), end use (research and academia, hospitals and clinics, pharmaceutical & biotechnology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global NGS-Based RNA-Sequencing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global NGS-Based RNA-Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global NGS-Based RNA-Sequencing Market by Product Type
    • 3.3.1: Sample Preparation Products
    • 3.3.2: RNA-sequencing Platforms and Consumables
    • 3.3.3: RNA-sequencing Services
    • 3.3.4: Data Analysis, Storage & Management
  • 3.4: Global NGS-Based RNA-Sequencing Market by Technology
    • 3.4.1: Sequencing by Synthesis
    • 3.4.2: Ion Semiconductor Sequencing
    • 3.4.3: Single-molecule Real-time Sequencing
    • 3.4.4: Nanopore Sequencing
  • 3.5: Global NGS-Based RNA-Sequencing Market by Application
    • 3.5.1: Expression Profiling Analysis
    • 3.5.2: Small RNA-Sequencing
    • 3.5.3: De Novo Transcriptome Assembly
    • 3.5.4: Variant Calling & Transcriptome Epigenetics
    • 3.5.5: Others
  • 3.6: Global NGS-Based RNA-Sequencing Market by End Use
    • 3.6.1: Research and Academia
    • 3.6.2: Hospitals and Clinics
    • 3.6.3: Pharmaceutical & Biotechnology
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global NGS-Based RNA-Sequencing Market by Region
  • 4.2: North American NGS-Based RNA-Sequencing Market
    • 4.2.1: North American NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.2.2: North American NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.3: European NGS-Based RNA-Sequencing Market
    • 4.3.1: European NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.3.2: European NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.4: APAC NGS-Based RNA-Sequencing Market
    • 4.4.1: APAC NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.4.2: APAC NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.5: ROW NGS-Based RNA-Sequencing Market
    • 4.5.1: ROW NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.5.2: ROW NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Product Type
    • 6.1.2: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Technology
    • 6.1.3: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Application
    • 6.1.4: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by End Use
    • 6.1.5: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Region
  • 6.2: Emerging Trends in the Global NGS-Based RNA-Sequencing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global NGS-Based RNA-Sequencing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global NGS-Based RNA-Sequencing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Illumina
  • 7.2: Thermo Fischer Scientific
  • 7.3: Oxford Nanopore Technologies
  • 7.4: Agilent Technologies
  • 7.5: BGI